Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.

Gustafsson PA, Birberg-Thornberg U, Duchén K, Landgren M, Malmberg K, Pelling H, Strandvik B, Karlsson T.

Acta Paediatr. 2010 Oct;99(10):1540-9. doi: 10.1111/j.1651-2227.2010.01871.x. Epub 2010 Jun 8.

PMID:
20491709
2.

Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis.

Bloch MH, Qawasmi A.

J Am Acad Child Adolesc Psychiatry. 2011 Oct;50(10):991-1000. doi: 10.1016/j.jaac.2011.06.008. Epub 2011 Aug 12. Review.

3.

[Omega-3 and omega-6 fatty acids in the treatment of children and adolescents with ADHD].

Aben A, Danckaerts M.

Tijdschr Psychiatr. 2010;52(2):89-97. Review. Dutch.

5.

Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review.

Raz R, Gabis L.

Dev Med Child Neurol. 2009 Aug;51(8):580-92. doi: 10.1111/j.1469-8749.2009.03351.x. Epub 2009 Jun 22. Review.

6.

Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children.

Schuchardt JP, Huss M, Stauss-Grabo M, Hahn A.

Eur J Pediatr. 2010 Feb;169(2):149-64. doi: 10.1007/s00431-009-1035-8. Epub 2009 Aug 12. Review.

PMID:
19672626
7.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
8.

Omega-3 fatty acids in ADHD and related neurodevelopmental disorders.

Richardson AJ.

Int Rev Psychiatry. 2006 Apr;18(2):155-72. Review.

PMID:
16777670
9.

Attention deficit disorders--drugs or nutrition?

Matsudaira T.

Nutr Health. 2007;19(1-2):57-60. Review.

PMID:
18309764
10.

Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder.

Burgess JR, Stevens L, Zhang W, Peck L.

Am J Clin Nutr. 2000 Jan;71(1 Suppl):327S-30S. Review.

11.

Omega-3 fatty acids and neuropsychiatric disorders.

Young G, Conquer J.

Reprod Nutr Dev. 2005 Jan-Feb;45(1):1-28. Review.

PMID:
15865053
12.

[The treatment of Attention-Deficit/Hyperactivity Disorders with polyunsaturated fatty acids - an effective treatment alternative?].

Frölich J, Döpfner M.

Z Kinder Jugendpsychiatr Psychother. 2008 Mar;36(2):109-16. doi: 10.1024/1422-4917.36.2.109. Review. German.

PMID:
18622940
13.

Nutritional supplements for the treatment of ADHD.

Bloch MH, Mulqueen J.

Child Adolesc Psychiatr Clin N Am. 2014 Oct;23(4):883-97. doi: 10.1016/j.chc.2014.05.002. Epub 2014 Aug 12. Review.

14.

Application of fatty acid and lipid measurements in neuropsychiatry.

Grela A, Rachel W, Cole M, Zyss T, Zięba A, Piekoszewski W.

Clin Chem Lab Med. 2016 Feb;54(2):197-206. doi: 10.1515/cclm-2015-0394. Review.

15.

[The perspective lines of using standardized forms of omega-3 polyunsaturated fatty acids in neurology].

Gromova OA, Torshin IIu, Kalacheva AG, Grustlivaia UE, Kerimkulova NV, Grishina TR, Gusev EI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(1):101-5. Review. Russian. No abstract available.

PMID:
22701885

Supplemental Content

Support Center